Myers RH, Marans K, MacDonald ME. Huntington’s disease. In: Genetic instabilities and hereditary neurological diseases (Warren ST, Wells RT, eds), pp 301–323. New York: Academic Press, 1998. Google Scholar
Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, Tanzi RE et al. A polymorphic DNA marker genetically linked to Huntington’s disease.Nature 306: 234–238, 1983. ArticlePubMedCAS Google Scholar
The Huntington’ s Disease Research Collaborative Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes.Cell 72: 971–983, 1993. Article Google Scholar
Duyao MP, Ambrose CM, Myers RH, Novelletto A, Persichetti F, Frontali M et al. Trinucleotide repeat length: instability and age of onset in Huntington’s disease.Nat Genet 4: 387–392, 1993. ArticlePubMedCAS Google Scholar
Chong SS, Almqvist E, Telenius H, LaTray L, Nichol K, Bourdelat-Parks B et al. Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analyses.Hum Mol Genet 6: 301–309, 1997. ArticlePubMedCAS Google Scholar
Maat-Kievit A, Losekoot M, Van Den Boer-Van Den Berg H, Van Ommen GJ, Niermeijer M, Breuning M et al. New problems in testing for Huntington’s disease: the issue of intermediate and reduced penetrance alleles.J Med Genet 38: E12, 2001. ArticlePubMedCAS Google Scholar
Merritt AD, Conneally PM, Rahman NF, Drew AL. Juvenile Huntington’s chorea. In: Progress in neurogenetics. (Barbeau A, Brunette TR, eds), pp 645–650. Amsterdam: Excerpta Medica Foundation, 1969. Google Scholar
Zühlke C, Olaf R, Bockel B, Lange H, Thies U. Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene.Hum Mol Genet 2: 2063–2067, 1993. ArticlePubMed Google Scholar
Ranen NG, Stine CO, Abbott MH, Sherr M, Codori AM, Franz ML et al. Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington’s disease.Am J Hum Genet 57: 593–602, 1995. PubMedCAS Google Scholar
Djoussé L, Knowlton B, Hayden M, Almqvist EW, Brinkman R, Ross C et al. Interaction of normal and expanded CAG repeat sizes influences age at onset of Huntington disease.Am J Med Genet 119a: 279–282, 2003. ArticlePubMed Google Scholar
Rosenblatt A, Brinkman RR, Liang KY, Almqvist EW, Margolis RL, Huang CY et al. Familial influence on age of onset among siblings with Huntington disease.Am J Med Genet 105: 399–403, 2001. ArticlePubMedCAS Google Scholar
Li J-L, Hayden M, Almqvist EW, Brinkman R, Durr A, Dode C et al. A genome scan for modifiers of age at onset in Huntington’s disease: the HD MAPS Study.Am J Hum Genet 73: 682–687, 2003. ArticlePubMedCAS Google Scholar
Bates G. Huntingtin aggregation and toxicity in Huntington’s disease.Lancet 361: 1642–1644, 2003. ArticlePubMedCAS Google Scholar
Beal MF. Coenzyme Q10 as a possible treatment for neurodegenerative diseases.Free Radic Res 36: 455–460, 2002. ArticlePubMed Google Scholar
Ross CA. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington’s disease and related disorders.Neuron 35: 819–822, 2002. ArticlePubMedCAS Google Scholar
Almqvist EW, Bloch M, Brinkman R, Craufurd D, Hayden MR. A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.Am J Hum Genet 64: 1293–1304, 1999. ArticlePubMedCAS Google Scholar
Taylor CA, Myers RH. Long-term psychological impact of Huntington’s disease linkage testing.Am J Med Genet 70: 365–370, 1997. ArticlePubMedCAS Google Scholar
Nance MA, Myers RH, and US Huntington Disease Genetic Testing Group. Trends in predictive and prenatal testing for Huntington disease, 1993–1999.Am J Hum Genet 65: A406, 1999. Google Scholar
Farrer LA. Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk.Am J Med Genet 24: 305–311, 1986. ArticlePubMedCAS Google Scholar
Schoenfeld M, Myers RH, Cupples LA, Berkman B, Sax DS, Clark E. Increased rate of suicide among patients with Huntington’s disease.J Neurol Neurosurg Psychiatry 47: 1283–1287, 1984. ArticlePubMedCAS Google Scholar
Almqvist EW, Elterman DS, MacLeod PM, Hayden MR. High incidence rate and absent family histories in one quarter of patients newly diagnosed with Huntington disease in British Columbia.Clin Genet 60: 198–205, 2001. ArticlePubMedCAS Google Scholar
Hayden MR. Huntington’s chorea. New York: Springer, 1981. Google Scholar
Visintainer CL, Matthias-Hagen V, Nance MA. U.S. Huntington Disease Genetic Testing Group. Anonymous predictive testing for Huntington’s disease in the United States.Genet Testing 5: 213–218, 2001. ArticleCAS Google Scholar
Tyler A, Morris M, Lazarou L, Meredith L, Myring J, Harper P. Presymptomatic testing for Huntington’s disease in Wales 1987–1990.Br J Psychiatry 161: 481–488, 1992. ArticlePubMedCAS Google Scholar
Hersch SM, Jones R, Koroshetz WJ, Quaid K. The neurogenetics genie: testing for the Huntington’s disease mutation.Neurology 44: 1369–1373, 1990. Google Scholar
Guidelines for the molecular genetics predictive testing Huntington’s disease.Neurology 44:1533–1536, 1994.
Pickering S, Polidoropoulos N, Caller J, Scriven P, Ogilvie CM, Braude P. Preimplantation Genetic Diagnosis Study Group. Strategies and outcomes of the first 100 cycles of preimplantation genetic diagnosis at the Guy’s and St. Thomas’ Center.Fertil Steril 79: 81–90, 2003. ArticlePubMed Google Scholar
Stern HJ, Harton GL, Sisson ME, Jones SL, Fallon LA, Thorsell LP et al. Non-disclosing preimplantation genetic diagnosis for Huntington disease.Prenat Diagn 22: 503–507, 2002. ArticlePubMedCAS Google Scholar